Click here for a PDF version of the program

Thursday, November 10, 2022

Simultaneous Pre-Congress Workshops-Require separate registration and are not included in the general congress registration fees. Click here to register.
Workshop A
Cryopreservation of ovarian tissue: Hands-on lab and clinics; tissue collection; lab preparation and tissue slow-freezing; transplantation techniques
Marie-Madeleine Dolmans, Belgium; Claus Yding Andersen, Denmark; Debra Gook, Australia; Jacques Donnez, Belgium; Linn Mamsen, Denmark; Luciana Cacciottola, Belgium
Register here
Workshop B
Oocyte Vitrification**: The Theory and Practice of human oocyte vitrification; factors influencing the outcomes in human ART. Hands-on training with animal oocytes.
Olga DeSilva, Denmark; Cornelia Meyer, Germany; Julie Jerumanis, Belgium;  Aaron Lakmaker, Spain** Workshop can be attended only by participants who have experience in handling mammalian oocytes

Sponsored by CooperSurgical

Register here
National session- FertiPROTEKT- Fertility preservation: what else matters?
Kenny A. Rodriguez-Wallberg, Sweden
Ralf Dittrich, Germany
Register here
National sessions – Asian Society for Fertility Preservation (ASFP) & The Fertility Preservation Society India (FPSI)
President ASFP – Dr. Nalini Kaul – Mahajan
Register here
Marie-Madeleine Dolmans, Belgium13:35-14:35

  • Practical aspects and manipulation of human ovarian tissue: from the surgery room to the cryovial.
    Linn Mamsen, Denmark
  • Slow-freezing and thawing of human ovarian tissue: cryobiology and quality assessment.
    Claus Yding Andersen, Denmark
  • Ovarian tissue transplantation: techniques and results.
    Jacques Donnez, Belgium
  • Practical aspects of establishing an ovarian tissue cryopreseravtion program.
    Debra Gook, Australia

Slow-Freezing of ovarian tissue: Hands-on practice with cow ovaries
Debra Gook, Australia; Marie-Madeleine Dolmans, Belgium; Linn Mamsen, Denmark; Luciana Cacciottola, Belgium; Paweena Thuwanut, Thailand; Rossella Masciangelo, Italy

Julie Jerumanis, Belgium13:35-14:30
Theory of vitrification and warming of oocytes
Cornelia Meyer, Germany; Olga DeSilva, Denmark

Hands-on training in vitrification and warming of oocytes
Olga DeSilva, Denmark; Cornelia Meyer, Germany; Aaron Lakmaker, Spain

** Workshop can be attended only by participants who have experience in handling mammalian oocytes

Before gonadotoxic therapy: Indications in different diseases
Michael Von Wolff, SwitzerlandDuring gonadotoxic therapy: Heavy uterine bleeding – prevention and treatment
Susanna Weidlinger, Switzerland

After gonadotoxic therapy: Endocrinological care
Ariane Germeyer, Germany

FertiPROTEKT –Data from the network
Jana Liebenthron, Germany

Asian Society for Fertility Preservation (ASFP) Session
Dr. T.M. Chau Le, Dr. Padma Rekha Jirge14:15-14:30
Fertility Preservation in Developing Countries – how far have we come
Dr. Virgilio M. Novero

Application of Ovarian tissue cryopreservation for benign condition
Prof. Nao Suzuki

Q & A

Fertility Preservation in Endometriosis
Prof. Budi Wiweko

Fertility Preservation for Benign conditions – Pros & Cons (Panel discussion)
Moderator: Dr. Nalini Kaul-Mahajan
Panelists: Prof. Nao Suzuki, Prof. Budi Wiweko, Dr. Mariam Faruqui (Shati), Dr. Virgilio M. Novero, Dr. T.M. Chau Le, Dr. Padma Rekha Jirge

The Fertility Preservation Society India (FPSI) Session

FP in oncological conditions – panel discussion (Case based discussion)
Moderators: Dr. Madhuri Patil
Panelists: Dr. Priya Selvaraj, Dr. Nymphaea Walecha, Dr. Tanya Buckshee Rohatgi, Dr. G. Buvaneswari, Dr. Shobhana, Dr. Shreyas Padgaonkar

Concluding Remarks
Prof. Nao Suzuki

Welcome Reception Supported by Visit Brussels
The welcome reception will be held in the Exhibition and Poster area, in the GALLERY.
All registered participants are invited to attend.

Friday, November 11, 2022

09:00-09:05 Welcome
Marie-Madeleine Dolmans, President of ISFP
09:05-09:20 Congress retrospective: 15 years of ISFP
Jacques Donnez, Belgium, Sam Kim, USA
09:20-09:45 Session 1: Opening lecture
Chairs: Jacques Donnez, Belgium, Sam Kim, USA, Hamish Wallace, UK
09:20-09:45 Fertility preservation: the recent changes and expectations
Marie- Madeleine Dolmans, Belgium
Cancer patients: what should be the criteria for fertility preservation?
Chairs: Herman Tournaye, Belgium, Sasmira Lalwani, USA
Industry-supported symposium by Ferring
09:45-10:15 Cancer patients: are the Edinburgh criteria for fertility preservation still accurate?
Richard Anderson, UK
10:15-10:45 Fertility preservation: what it is, what it is not and how best to do it
Glenn Schattman, USA
10:45-11:10 Coffee Break
11:10-12:50 Session 2: Fertility preservation in benign gynecological diseases
Chairs: Felice Petraglia, Italy, Bruno Salle, France
11:10-11:30 Adenomyosis, endometriosis, and fibroid-linked infertility: the mechanisms
Felice Petraglia, Italy
11:30-11:50 How to protect/restore fertility in case of uterine fibroids and adenomyosis?
Jacques Donnez, Belgium
11:50-12:10 How to preserve fertility in case of endometriosis?
Ana Cobo, Spain
12:10-12:30 How to preserve fertility in Turner syndrome patients?
Marie-Madeleine Dolmans, Belgium
12:30-12:50 Uterine transplantation: state of the art
Tommaso Falcone, USA
12:50-13:50 Lunch Break
13:50-15:30 Session 3: Andrology
Chairs: Herman Tournaye, Belgium, Nao Suzuki, Japan
13:50-14:10 Fertility preservation in boys: recent developments, challenges, and new insights
Jan-Bernd Stukenborg, Sweden
14:10-14:30 Preservation of fertility in transgender people
Pasquale Patrizio, USA
14:30-14:50 Fertility preservation in childhood cancer and prepubertal testicular tissue
Rod Mitchell, UK
14:50-15:10 Spermatogonial stem cells: from research to clinical relevance
Joachim Wistuba, Germany
15:10-15:30 Man-made human sperm: hope or hype
Yoni Baert, Belgium
15:30-15:50 Coffee Break
15:50-17:50 Session 4: IVM and poor responders
Chairs: Richard Anderson, USA, Michel De Vos, Belgium, Debra Gook, Australia
Part 1: IVM
15:50-16:10 Do we have arguments in favor of IVM alone in terms of live birth rate?
Michel De Vos, Belgium
16:10-16:30 A new frontier: developing human IVM based on oocytes obtained during fertility preservation procedures
Claus Yding Andersen, Denmark
16:30-16:50 A critical review of IVM: where are we really?
Kenny Rodriguez Wallberg, Sweden
Part 2: Poor responders
16:50-17:10 Is IVA the solution? Review of the literature and questions
Stine Gry Kristensen, Denmark
17:10-17:30 Rejuvenating the ovary by stem cell transplantation
Antonio Pellicer, Italy
17:30-17:50 Rejuvenating the oocyte: is mitochondrial or nucleus transfer the solution
Chii-Ruey Tzeng, Taiwan

Saturday, November 12, 2022

08:00-09:15 Session 5: Chemotherapy and ovaries
Chairs: Claus Yding Andersen, Denmark, Michael Von Wolff, Germany, Nalini Kaul-Mahajan, India
08:00-08:25 Mechanisms of ovarian damage from chemotherapy: apoptosis and/or follicle activation?
Dror Meirow, Israel
08:25-08:55 Is OTC after chemotherapy efficacious or contra-indicated?
The French experience- Catherine Poirot, France
The Israeli experience- Moran Shapira, Israel
08:55-09:15 How to counteract gonadatoxicity?
Isabelle Demeestere, Belgium
09:15-09:20 Technical Break
Updates in cryopreservation strategies
Chairman: Jacques Donnez, Belgium
Industry-supported symposium by GEDEON RICHTER
09:20-09:35 Egg freezing in oncological patients
Michel De Vos, Belgium
09:35-09:50 Egg freezing for social reasons or age-related fertility decline
Elisa Gil, Spain
09:50-10:05 Ovarian tissue freezing to delay menopause
Marie-Madeleine Dolmans, Belgium
10:05-10:20 Concluding remarks
Jacques Donnez, Belgium
10:20-10:40 Coffee Break
10:40-11:40 Session 6A: Six oral communication lectures (basic science)
Chairs: Isabelle Demeestere, Belgium, Dror Meirow, Israel
Session 6B: Six oral communication lectures (clinical science)
Chairs: Hamish Wallace, UK, Chii-Ruey Tzeng, Taiwan
10:40-10:50 Human umbilical cord perivascular cells (hucpvc) reduce ovarian fibrosis and improve pregnancy rates in a mouse model of natural ovarian aging
Andree Gauthier-Fisher, Canada
A pilot trial on the outcomes of fertility sparing treatment of atypical endometrial hyperplasia
Charissa Goh, Singapore
10:50-11:00 Importance of oxygen tension in human ovarian tissue in vitro culture
Francisco Vitale, Belgium
Follicular steroidogenesis in random start protocols for oocyte cryopreservation
Francesca Filippi, Italy
11:00-11:10 In vitro angiogenic stimulation of human ovarian tissue with small extracellular vesicles
Ana Sofia Pais, Portugal
Does ovarian tissue cryopreservation before neoadjuvant chemotherapy in breast cancer patient impact the ovarian recovery?
Christine Decanter, France
11:10-11:20 Novel anti-mullerian hormone receptor 2 binding peptide (amhr2bp) and its affinity to amh receptor 2
Laura Detti, USA
Ovarian tissue transplantation (OTT) for leukemia survivors
Hila Raanani, Israel
11:20-11:30 Targeting the akt/mtor pathways during ovarian tissue cryopreservation and transplantation with pharmacological inhibitors to preserve the primordial follicle reserve
Jules Bindels, Belgium
Reproductive outcomes following ovarian tissue grafting at a large tertiary level center
Kate Stern, Australia
11:30-11:40 Z-scores for comparative analyses of follicular density in ovarian cortex among children and young adultsz-scores for comparative analyses of follicular density in ovarian cortex among children and young adults
Jasmin Hassan, Sweden
What are the pregnancy and live birth rates in ovarian tissue transplantation and what factors are associated with success rates? Data from 196 women from the FERTIPROTEKT network
Laura Lotz, Germany
11:40-13:00 Session 7: Paving the way to the future
Chairs: Michelle Nisolle, Belgium, Jacques Donnez, Belgium, Evelyn Telfer, UK
11:40-12:00 The gamete microenvironment in iatrogenic and physiologic ovarian aging
Francesca Elizabeth Duncan, USA
12:00-12:20 How to improve revascularization of the ovarian transplants
Luciana Cacciottola, Belgium
12:20-12:40 From primordial follicle to mature oocyte: are we ready?
Evelyn Telfer, UK
12:40-13:00 Multiple facets of the ovarian ageing in mammals
Francesca Klinger
, Italy
13:00-14:00 Lunch Break
14:00-15:50 Session 8: Fertility preservation in breast and pelvic cancers
Chairs: Jean-Luc Squifflet, Belgium, Tommaso Falcone, USA/UK
Four oral communications, preselected for an award
14:00-14:10 Uterine volume is dramatically decreased after Childhood Hematopoietic Stem Cell Transplantation whatever the conditioning regimen. A case-control MRI study in a cohort of childhood acute leukemia survivors
Blandine Courbiere, France
14:10-14:20 Apoptosis and autophagy as determinants of ovarian reserve decline from birth to reproductive age in women undergoing ovarian tissue cryopreservation
Luciana Cacciottola, Belgium
14:20-14:30 Prior exposure to chemotherapy does not reduce the in-vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients
Tal Imbar, Israel
14:30-14:40 Human platelet lysate improve the growth and survival of isolated human pre-antral follicles in vitro
Cristina Subiran Adrados, Denmark
14:40-15:30 Keynote lecture:
Conservative surgery in ovarian cancer, BOT and cervical cancer
Catherine Uzan, France
15:30-15:50 Fertility preservation in women with breast cancer
Michael Von Wolff, Germany
15:50-16:15 Closing remarks
Marie-Madeleine Dolmans, Belgium
16:15 Award and closing ceremony